Emotional Brain conducts research into the causes of and treatments for FSIAD. Our aim is to advance our scientific knowledge about FSIAD and to develop new treatments and medications to help women who are suffering from this condition.
Since 2004, Emotional Brain has conducted over 20 Phase 1 and Phase 2A studies for two advanced medical treatment options with a dual mechanism of action: Lybrido and Lybridos. Large-scale Phase 2B studies have been conducted in 17 research sites in the US (2011-2014).
Our studies in the United States have been reviewed and approved by IRB’s (Institutional Review Boards). The Medical Research Ethics Committee (METC; Dutch review board) has reviewed and approved the studies in the Netherlands.